"After years of bipartisan deliberation, U.S. Sen. Tim Kaine, D-Va., has introduced legislation to strengthen and protect a federal drug pricing program.
[...]
To strengthen the program, Kaine’s new bill would prescribe new annual reporting requirements for participants and give the Department of Health and Human Services auditing authority.
[...]
A pillar of the bill, Kaine said, is protecting up-front discounts for participating providers rather than the rebate model some of his colleagues and President Donald Trump have favored."